-The Times of India An average Indian man's life expectancy (LE) at birth has increased by nearly 15 years in the last 40 years, while an average Indian woman is living over 18 years longer than what she did four decades ago. The world population's life span has gained more than a decade since 1970 - from 56.4 years in 1970 to 67.5 years in 2010 for an average male and from...
More »SEARCH RESULT
Combating a killer-Dr. PK Rajagopalan
-Frontline There are no effective vaccines against Japanese encephalitis, but its spread can be controlled in India through vector management. JAPANESE ENCEPHALITIS, or JE, has become endemic in many parts of the country, occurring repeatedly in epidemic form in many of them—for instance, in parts of Gorakhpur in northern Uttar Pradesh. One can expect JE-type epidemics year after year in States where prolonged drought-like conditions are followed by heavy monsoons. This leads to...
More »‘New drugs, generics both needed for total healthcare’
-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...
More »Drug makers may dodge price control-Sushmi Dey
-The Business Standard The proposed pharma pricing policy may give room to drug makers to escape price control. While the policy is primarily aimed at making essential medicines affordable, many feel the spirit is missing in the recommendations put forward by a group of ministers a few days ago. For instance, the ministerial panel has proposed to regulate prices of only 348 essential medicines and keep combination products out of control —...
More »Panel backs market say in drug prices
-The Telegraph A panel of Union ministers today finalised a market-based drug pricing policy that public health experts say cold-shoulders concerns expressed by the health ministry and threatens to legitimise high prices for medicines. The policy finalised by the group of ministers (GoM), led by Sharad Pawar, will apply to 348 essential drugs to cover virtually all common ailments — from painkillers and antibiotics to asthma medications and drugs against high blood...
More »